The newest Mobile Suit Gundam series' movie prequel stylishly sets the stage for a show that's bursting with incredible potential. Mobile Suit Gundam has spent 45 years being in almost constant ...

The Spring 2025 Anime Season includes a special Mobile Suit Gundam series: Gundam GQuuuuuuX ("G-Quacks"). It is the latest installment in the main Gundam franchise and the second to feature a ...

In a newly-released promotional video via official Gundam outlets, a release date for Mobile Suit Gundam GQuuuuuuX’s TV anime has been confirmed. Directed by industry veteran Kazuya Tsurumaki ...

Amazon Prime Video will exclusively stream Gundam GQuuuuuX globally, subbed and dubbed simultaneously with Japanese broadcast starting April 8. The series is set in an alternate timeline of Gundam ...

The second episode of the Enter The Garden anthology series will have Yukio Takatsu acting as the director, who anime fans might know for their work on Naruto Shippuden, Monogatari, Lupin The ...

It's only been six months since Warhammer 40K: Space Marine 2's well-received arrival, but developer Saber Interactive would already like you to know it's working on a sequel. Yup, Space Marine 3 ...

Crunchyroll does feature quite a few Gundam series, including The Witch From Mercury, so there’s a chance that it’ll license GQuuuuuuX for streaming as well. Mobile Suit Gundam GQuuuuuuX is a ...

The Wing Gundam Zero is perhaps the most Gundam of all the modern Gundams. For better and worse. We break it down.

What are the best Warhammer 40K games? Games Workshop’s grimdark ... put you in close contact with Chaos Marines, Orks, and the Tau Empire, and only one of you is making it out alive.

A new study from Mass General Brigham researchers has found faster accumulation of tau-a key indicator of Alzheimer's disease-in the brains of women over the age of 70 who took menopausal hormone ...

Check out this weekend's top news: explore the Drukahri's Dark City, learn how to take down a D&D Fighter, and Necromunda pre ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...